Posted on

Hollister Biosciences Inc. Division Hollister Cannabis Co is Making & Donating Hand Sanitizer to Hollister, CA

Vancouver, BC, March 24, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB) (the “Company” or “Hollister”) – through its Hollister Cannabis Co division, is stepping up to manufacture and distribute a few thousand bottles of hand sanitizer to Hollister, CA.

A statewide “shelter at home” mandate has been issued for California, putting a halt to non-essential manufacturing and delay in distribution. Cannabis retailers and manufacturers are considered essential businesses in California. In the wake of the COVID-19 pandemic, Hollister is using its essential business standing and facility to source and produce hand sanitizer for its local community.

Hollister will be giving its first batch of hand sanitizer to the Hollister food bank. Multiple batches of hand sanitizer are expected to be delivered to community organizations over the next few weeks.

The CEO of Hollister Biosciences Inc, Carl Saling, shared: “The community of Hollister, CA is near and dear to our hearts, and as the first licensed cannabis company in the city of Hollister, CA, I feel that we must do whatever we can to help.

It infuriated me seeing companies price gouging much needed items, such as hand sanitizer.  I am all for making money, but not at the expense of playing on people’s fears during a time of crisis. We just had to act.

We are going to focus on donating to the facilities that are often overlooked: the food bank, nursing homes, rehabilitation centers, and homeless shelters, where some of the most vulnerable are sheltering in place.

I am calling all business owners to step up in this time of crisis and do whatever you can to help your local community.”

About Hollister Biosciences Inc.
Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”

Website:  www.hollistercannabisco.com


HOLLISTER BIOSCIENCES INC.:

Company Contact:
Carl@hollisterchc.com
Tel: (831) 777-3276

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

As Released on: Newswire

Posted on

Hollister Biosciences Enters Letter of Intent to Acquire Alphamind Brands

Vancouver, BC, March 10th, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister”) – a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that the Company has entered into a letter of intent (the “LOI”) on March 9th, 2020 to acquire Alphamind Brands ( “Alphamind”), a company developing legal mushroom based natural health products and conducting R&D in conjunction with accredited universities to develop psilocybin based compounds for drug development.

The all stock purchase price is anticipated to be CDN$1,200,000 with such payment to be made in Hollister common stock.  The stock price will be determined based on the greater of the 14-day VWAP (Volume Weighted Average Price) subsequent to announcing the transaction and $0.20.  The acquisition subject to normal course due diligence.

“We are very pleased to have entered into an LOI to complete this very exciting acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences, Inc.  “It is a fundamental value of our company to improve the overall health and performance of our customers through our high-quality products and the health benefits associated with medicinal mushrooms are tremendous.  Not to mention, it is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering.”

“I think we have a found a great partner in Hollister”, shared Rob Cunningham, CEO of Alphamind Brands.  “We have medicinal mushroom based product SKU’s ready to ship and R&D is underway to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments.  Being under the Hollister umbrella will allow us to access additional markets and leverage their existing manufacturing and distribution infrastructure and will be a fundamental part of the future growth of our business.”

In association with the arm’s length transaction, Hollister will not be assuming any long-term debt and there is no change in Management, or the Board of Directors of Hollister being contemplated at this time.

About Hollister Biosciences Inc.
Hollister Biosciences Inc. is a diversified cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model.

Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide.

Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success.

Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.

Website:  www.hollistercannabisco.com


About Alphamind Brands
Alphamind Brands is a Canada and US based growth stage company developing a portfolio of legal mushroom based natural health products as well as conducting R&D initiatives, led by Dr. Nikos Apostolopoulos, to explore psilocybin based pharmaceutical treatments.   The company operates out of an FDA and GMP certified 25,000 Sqft facility in Oregon, USA. The company’s “ready to ship” product SKU’s include cordyceps, lion’s mane, chaga and reishi mushroom based: liquid cordyceps, concentrated mushroom powder, tea, chocolate.  The company’s product SKU’s under development include syrups, elixirs, cold beverages and nasal spray.

 

HOLLISTER BIOSCIENCES INC.:

Company Contact:
klee@k2capital.ca
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

As Released on: Newsire

Posted on

Hollister Biosciences Signs Definitive Agreement to Acquire Venom Extracts With $16.4 Million in Revenue and $2.48 Million EBITDA

Vancouver, BC, March 06, 2020 — Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister”), a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that further to the signing of the definitive agreement on March 6th, 2020, the Company has now closed its transformational acquisition of Venom Extracts (“Venom Extracts”), a leading Arizona cannabis extract brand and one of the state’s largest producers of award-winning medical cannabis distillate and related products.

HIGHLY ACCRETIVE $20,000,000 ACQUISITION, ADDING CDN$16.4 MILLION OF 2019 REVENUE

For the year ended December 31, 2019, Venom Extracts reports having generated CDN$16.4 million in revenue and CDN$2.5 million in EBITDA from its product line of cannabis concentrates and cartridges as reported by Management. The auditor confirmed via a comfort letter that Venom Extract’s 2019 revenues are materially as represented by Management.  Venom Extract’s Management also reports a strong start to 2020, having generated revenue of CDN$ 2.4 million in January of 2020 and CDN$2.4 million in February of 2020.

The all-stock purchase price of CDN$20,000,000 represents a transaction multiple of 1.2x 2019 revenue, with 70% of the consideration paid upfront and the 30% balance to be paid upon milestone achievements related to revenue targets for Venom Extracts. After conducting normal course due diligence, the acquisition is now closed.

KEY TERMS:

The Company has acquired Venom Extracts for CDN$20,000,000 with such payment to be issued in Hollister common stock (the “Payment Shares”).

  •   The stock price upon which the Payment Shares have been calculated is CDN$0.20 per Hollister share.
  •   The initial 70% of the Payment Shares have been issued, subject to hold periods.
  •   The remaining 30% of the Payment Shares will be issued when and if the following milestones have been met on or prior to December 31st, 2021:
    • 20% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$30,000,000 (calculated in accordance with IFRS from January 1, 2020).
    • 10% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$40,000,000 (calculated in accordance with IFRS from January 1, 2020).

“We are extremely pleased to complete this transformational and highly accretive acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences Inc. “Our acquisition of Venom Extracts bolts on substantial revenue and EBITDA to Hollister, while providing Venom Extracts the ability to expand its offering of premium branded product into the California marketplace. Likewise, our acquisition also allows Hollister to introduce its products into the Arizona and Nevada marketplaces through Venom Extracts’ existing distribution channels.”

“This is an exciting acquisition and we are very pleased to announce closing”, shared Jacob Cohen, Founder of Venom Extracts.  “This transaction represents the next step in ensuring the future growth of both Hollister and Venom. We are looking forward to increasing our geographic presence by expanding into the California marketplace through Hollister’s existing platform, and exploring expansion of our existing product portfolio collectively.”

In association with the acquisition, Hollister will not be assuming any long-term debt, a new control position will be created and there is no change in Management, or the Board of Directors of Hollister being contemplated at this time.

Finder’s fees will be payable in accordance with the policies of the Canadian Securities Exchange.

This press release is available on the Company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

 

About Hollister Biosciences Inc.
Hollister Biosciences Inc. is a diversified cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model.

Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide.

Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success.

Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.

Website:  www.hollistercannabisco.com

 

About Venom Extracts
Venom Extracts is one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.  With an experienced management team and unparalleled reputation for quality, Venom Extracts prides itself as a differentiated extraction company by producing legal Marijuana products at a price point that allows retailers to generate higher profits.  Focused on proprietary efficiencies, the Company is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company. The company’s expansion strategy is centered on entering new markets/states that are approved for medical cannabis use and/or approved or have a reasonable expectation to be approved for recreational use in the near future.

Website:  www.venomextracts.com


HOLLISTER BIOSCIENCES INC.:

Company Contact:
klee@k2capital.ca
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

As Released on: Newswire

Posted on

Hollister Biosciences Inc. Signs Letter of Intent to Acquire Venom Extracts With $16.4 Million In Revenue And $2.48 Million EBITDA

Vancouver, BC, February 25, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister”) – a vertically integrated cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that the Company signed a Letter of Intent (“LOI”) on February 20th, 2020 to acquire Venom Extracts (“Venom”), one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.

HIGHLY ACCRETIVE $20,000,000 ACQUISITION: For the year ended December 31, 2019, Venom Extracts reports having generated CDN$16.4 million in revenue and CDN$2.48 million in EBIDTA from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges. Hollister cautions that revenue and EBITDA figures have not yet been audited and are based on reports prepared by Venom management. Though Hollister believes the figures to be highly reliable, their audit will be part of the due diligence before closing.

The all stock purchase price is anticipated to be CDN$20,000,000, with 70% to be paid upfront and 30% to be paid upon milestone achievements. The acquisition is expected to close by March 31, 2020 subject to normal course due diligence.

“Venom has established itself as a leading extraction operation with a prominent brand in the Arizona marketplace”, said Carl Saling, Founder and CEO of Hollister Biosciences Inc.  “We feel this acquisition will present a great deal of opportunity for synergy between Hollister and Venom, providing avenues for both companies into the Arizona, California and additional marketplaces for cannabis products.  Venom Extracts has a highly skilled and experienced management team with a track record for operational excellence. This transaction is highly accretive and represents a fundamental part of the future growth of both companies.”

LOI TERMS: The terms of the LOI, which will be formalized by a definitive agreement on closing, are as follows:

  • The Company will acquire Venom Extracts for CDN$20,000,000 with such payment to be issued in Hollister common stock (the “Payment Shares”)
  • The stock price will be determined based on the greater of: The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
  • Once the share price is established, 70% of the Payment Shares will be issued upon closing of the transaction, subject to hold periods.
  • The remaining 30% of the Payment Shares will be issued when and if the following milestones have been met on or prior to December 31st, 2021: 20% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$ 30,000,000 (calculated in accordance with IFRS from January 1, 2020), and 10% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$40,000,000 (calculated in accordance with IFRS from January 1, 2020).

“We are very pleased to be entering into this transaction with Hollister”, shared Mason Cave, CEO of Venom Extracts.  “The opportunities for resource and capability sharing between the two companies are plentiful. This also represents a more expeditious avenue for us into the large and rapidly growing California marketplace.  Hollister has an excellent management team in place and has established itself as a sought-after brand house of popular cannabis and hemp products in California. We feel that our contribution on the extraction side will help diversify Hollister’s product offering and continue to build out the brand equity of both companies across multiple state and eventually global marketplaces”

In association with the arm’s length transaction, Hollister will not be assuming any long-term debt, a new control position will be created and there is no change in Management, or the Board of Directors of Hollister being contemplated at this time.

Finder’s fees will be payable in accordance with the policies of the Canadian Securities Exchange.

About Venom Extracts:
Venom Extracts is one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.  With an experienced management team and unparalleled reputation for quality, Venom Extracts prides itself as a differentiated extraction company by producing legal Marijuana products at a price point that allows retailers to generate higher profits.  Focused on proprietary efficiencies, the Company is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company. The company’s expansion strategy is centered on entering new markets/states that are approved for medical cannabis use and/or approved or have a reasonable expectation to be approved for recreational use in the near future.
Website:  www.venomextracts.com

About Hollister Biosciences Inc.:
Hollister Biosciences Inc. is a vertically integrated cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model. Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide. Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures
Website:  www.hollistercannabisco.com
Company Contact:
klee@k2capital.ca
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

Also Released on: Newsire

Posted on

Hollister Biosciences Inc. Division Hollister Cannabis Co’s HashBone Brand to Launch MiniBone Pre-Roll Packs

Vancouver, BC, February 20, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB) (the “Company” or “Hollister”) – through its Hollister Cannabis Co division, is proud to announce the launch of its 5-pack of .5g hash-infused pre-rolls, HashBone MiniBones.

HashBones are the #1 hash-infused pre-roll in California. Each 1G HashBone is hand-packed with an artisan blend of 25% cold water bubble hash and 75% top-shelf flower. Each HashBone features a pair of sativa, hybrid or indica strains, boasting enhanced flavor and potency. Flower is sourced from California’s Central Coast, while the cold water bubble hash is made by Hollister.

The 5-pack of .5g hash-infused pre-rolls, HashBone MiniBones, will be distributed exclusively by Hollister Cannabis Co.’s distribution partner, Indus Holdings, Inc. (CSE: INDS) and is anticipated to launch by April 01, 2020. HashBone MiniBones are expected to retail at an average price of $30 (plus tax). Based on HashBone’s current customer base, we forecast demand for 65,000 units in 2020.

The CEO of Hollister Biosciences Inc., Carl Saling shared, “Our customers have been requesting a multi pack HashBone that would be great on the go. We are thrilled to launch the 5 pack mini bone hash infused pre rolls.“

About Hollister Biosciences Inc.:
Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”
Website:  www.hollistercannabisco.com
Company Contact:
klee@k2capital.ca
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

As Released on: Newsire

Posted on

Hollister Biosciences Inc. Division Rebel Hemp Company to Launch Line of Premium Hemp Pre-Rolls

Vancouver, BC, February 18th, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB (the “Company“, “Hollister Cannabis Co.” or “Hollister“) – through its hemp division, Rebel Hemp Company, is proud to announce the launch of its premium hemp pre-rolls.

Hollister has entered a letter of intent (“LOI’) for a proposed offtake agreement (the “Agreement”) with Mountain Financial Solutions LLC (“Mountain Financial”). Under the terms of this Agreement, Hollister will purchase 1,000 pounds of hemp from Mountain Financial for use in various smokable hemp products – specifically, Rebel Hemp Company’s premium hemp pre-rolls.

Rebel Hemp Company’s pre-rolls will be sold as singles and in packs. All hemp pre-rolls for Rebel Hemp Company will be manufactured by Hollister, using the smokable hemp sourced from Mountain Financial’s farm in Paso Robles, CA. The selected CBD-rich hemp strains will provide smokers with a consistent, flavorful and relaxing experience.

Ronald Hodge, of Mountain Financial Solutions, spoke about the Agreement: “We are happy to announce our agreement with Hollister Cannabis Co and look forward to a long lasting relationship. I have known Carl for over 20 years and he’s one of the best in the business.”

Carl Saling, Founder, CEO and Director of Hollister Biosciences Inc, shared: “We are very excited to be working with Mountain Financial Solutions LLC. Their unique high CBD hemp strains are just what we were looking for to launch our smokable hemp pre roll line.”

About Mountain Financial Solutions LLC:
Mountain Financial Solutions, LLC is located in the Paso Robles wine region of California. They currently grow multiple strains of smokable hemp on a 100 acre farm, surrounded by beautiful vineyards. Their flower is considered the highest quality hemp in California.

About Hollister Biosciences Inc.:
Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”
Website:  www.hollistercannabisco.com
Company Contact:
klee@k2capital.ca
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

As Released on: Newswire

Posted on

Hollister Biosciences Inc. To Manufacture and Distribute Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1

 

 

Vancouver, BC, February 7th, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB) (the “Company”, “Hollister Cannabis Co” or “Hollister”) is proud to announce its licensing agreement with Tommy Chong to manufacture and distribute Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1.

 

The tincture, branded Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1, features a 1:1 ratio of THC to CBD, recognized for its medicinal properties. True to the manufacturing mission of Hollister Cannabis Co., the 1:1 tincture is crafted in small, artisanal batches for optimal quality and made from premium California-grown cannabis.

 

The tincture, Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1, will be distributed exclusively by Hollister Cannabis Co.’s distribution partner, Indus Holdings, Inc. and is anticipated to be in-dispensaries throughout California by March 01, 2020. Hollister is anticipating producing up to 25,000 units of Tommy Chong’s Cannabis™ Full Spectrum Elixir 1:1 during the 1st 12 months of executing the agreement with an estimated retail price of $70 per unit all sold through Hollister’s distribution partner.

 

In discussing the partnership with Hollister Cannabis Co., Tommy Chong shared, “I only partner with the best-in-class companies and I am really pleased to have the Hollister Cannabis Co bring their amazing Tommy Chong’s Cannabis™ Full Spectrum Elixir to the market for me”.

 

Hollister Cannabis Co., CEO, Carl Saling shared, “We are honored and excited to be partners with such a legendary and Iconic star as Tommy Chong. Tommy has experienced the medical benefits of cannabis and we are looking forward to working together to launch Tommy Chong’s Cannabis Full Spectrum Elixir into the California Legal Cannabis marketplace.”.

 

 

About Tommy Chong’s Cannabis:
As one-half of the legendary comedy duo Cheech & Chong, Tommy Chong helped pioneer a completely unique brand of comedy directed at the counter-culture movement of the early ‘70s. At the heart of this brand of entertainment was cannabis. On-screen and off Tommy became a vocal advocate for his favorite herb. In a time where cannabis had to be talked about in whispers, Tommy was a loud voice for the advocacy movement, working tirelessly to destigmatize the use of this healing plant. With the legalization of recreational cannabis, Tommy’s voice continues to ring out loudly, touting its benefits and place in society. Now, Tommy is thrilled to share that passion and knowledge of cannabis with the rest of the world. Using his lifelong connections in the industry, he has made it his personal mission to share the very best product available with his fans and fellow herb connoisseurs. If anyone knows weed, its Tommy. And now fans of comedy and cannabis alike can experience the strains and products that Tommy himself has hand selected.

 

 

About Hollister Biosciences Inc.:
Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”
Website:  www.hollistercannabisco.com
Company Contact:
klee@k2capital.ca
Tel: 604-961-0296

 

 

 

 

 

 

 

 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

As Released on: Newswire

Posted on

Hollister Biosciences Inc. and Veteran Based Tactical Relief Enter into Letter of Intent for Proposed Joint Venture Agreement

Vancouver, BC, February 7, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB) (the “Company” or “Hollister”) is pleased to announce that it has entered into a letter of intent (the “LOI”) to complete a Joint Venture Agreement (the “Joint Venture” or the “Agreement”) with Tactical Relief, a Veteran-founded hemp-based CBD oil brand. Upon completion of the Agreement, Hollister and Tactical Relief will collaborate on the development and marketing of cannabis tinctures throughout the California market.

Branded under Tactical Relief, the first cannabis tincture to be manufactured will feature a 20:1 ratio of THC to CBD, recognized for its medicinal properties in treating PTSD. True to the manufacturing mission of Hollister, the 20:1 tincture is crafted in small, artisanal batches for optimal quality and made from premium California-grown cannabis.

Under the terms of the Agreement, Tactical Relief will contribute artwork, logos and package design for a series of cannabis tinctures. On an ongoing basis, Tactical Relief will be financially responsible for all design and marketing. Hollister will be responsible for all aspects of production and procurement of underlying materials. All production of cannabis products will take place under Hollister’s supervision and licenses, and Hollister will be responsible for all costs associated with production and shipping. Tactical Relief and Hollister will further explore the development and marketing of additional cannabis-based tinctures, as well as expanding into out-of-state markets over coming years.

Tactical Relief’s new tincture(s) will be distributed exclusively by Hollister’s distribution partner, Indus Holdings Inc. (CSE: INDS)  and is anticipated to be in dispensaries throughout California by March 01, 2020. An estimated 5% net profits of all sales will be donated to charity.  Revenue generated on the tincture product line will be shared 60:40 between Hollister and Tactical Relief.

“Tactical Relief is a patriotic brand with a powerful message,” said Adam Smith, a Green Beret veteran, and Co-Founder of the Tactical Relief brand and US representative at Allied. “We launched this product to change the ways in which veterans and first-responders suffering from PTSD can choose to treat themselves, and with the Hollister Biosciences strategic alliance, we will be able to provide even more alternative treatments to those suffering. Part of the Tactical Relief mission is to use as many holistic treatment methods that have been shown to assist with post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). This partnership with Hollister Biosciences will help move this mission forward.”

“It’s always been our vision to share the wellness benefits of the cannabis plant with as many people as we possibly can,” said Carl Saling, Founder, CEO and Director of Hollister Biosciences Inc. “We take great pride in providing only the highest quality products and innovation, and we are excited to be teaming up with TACTICAL RELIEF™ to reach new audiences and help out those who have sacrificed so much for us all.”

About Tactical Relief:
Started by a Green Beret and trainer of Law Enforcement, Tactical Relief creates, promotes and sells the highest quality and most patriotic CBD oils in the country. Tactical Relief’s CBD oils are full spectrum, and currently made from the highest quality hemp grown in Kentucky. Owner Adam Smith is a Green Beret with nearly 17 years in service and experienced firsthand how CBD can help retired and active-duty (military and law enforcement) ease their physical and mental issues – especially those who suffer from PTSD and TBI. Tactical Relief is on a mission to end the stigma around hemp and cannabis products, and to provide relief to as many service members as possible.
Website: https://tacticalrelief.com/

About Hollister Biosciences Inc.:
Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”
Website:  www.hollistercannabisco.com
Company Contact:
klee@k2capital.ca
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 

As Released on: Newswire

Posted on

Hollister Biosciences Inc. and ER71 USA Inc. “Easyriders” Enter into LOI for Proposed Joint Venture Agreement

Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB) (the “Company“, or “Hollister“), a California based cannabis and hemp branding company with a vision to be the sought-after premium brand portfolio of innovative, high-quality Californian-grown cannabis & hemp products and ER71 USA Inc. (“Easyriders“) an iconic brand with millions of followers globally, are pleased to announce that they have entered into a letter of intent (the “LOI“) to complete a joint venture agreement (the “Joint Venture“, or the “Agreement“).  Upon completion of the Joint Venture, Hollister and Easyriders will collaborate on the development and marketing of co-branded hemp-based everyday premium product lines.  Execution of the Agreement is subject to obtaining consumer data and leveraging convenience store relationships to forecast revenue from a co-branded hemp product line.

Hollister is proud to announce its partnership with Easyriders as the brand’s official marketing partner. From the birthplace of the American Biker, Hollister is the first licensed and operational cannabis and hemp company in Hollister, California with a mission to embrace the outlaw roots of Hollister, while providing premium-quality hemp products.

Under the terms of the Agreement, Easyriders will contribute artwork, logos and package design for a series of pre-rolled products using hemp.  On an ongoing basis, Easyriders will be financially responsible for all design areas as well as packaging designs and be financially responsible for marketing that is a percentage of revenue for the co-branded product line. Hollister will be responsible for all aspects of production and procurement of underlying materials.  All production of hemp products will take place under Hollister’s supervision and licenses and Hollister will be responsible for all costs associated with production which includes the cost of producing and shipping the products.  Easyriders and Hollister will further explore the development and marketing of additional product SKU’s for hemp-based edibles, vapes, topicals, and beverages.  Revenue generated on the co-branded product lines will be shared 50:50 between Easyriders and Hollister.

The partnership between Hollister and Easyriders will be officially announced at the Dream House MJBiz VIP Event in Las Vegas, Nevada. The most-anticipated after-party of the MJBiz Conference presented by Farechild will take place on December 12, 2019, in close proximity to the famous Las Vegas strip. Hollister is the event’s premier sponsor, offering VIP’s an exclusive on-site adult consumption area in “The Den.”

Easyriders shared, “We at Easyriders are excited about the opportunity to explore this new category with a reputable company such as Hollister. Both companies are based in California and both have deep roots in the motorcycle world. It makes sense that we do this together.”

In discussing the partnership with Easyriders, CEO of Hollister, Carl Saling shared, “I cannot think of a better partnership. As Hollister, California is the birthplace of the American Biker, I feel we’re paying homage to the rebel spirit Hollister embodies with the official Easyriders partnership.”

About Easyriders.

In 1970, Easyriders established itself as a platform for motorcycle enthusiasts to immerse in the rugged, on-the-road lifestyle championed by the counterculture movement and greats including Steve McQueen, Peter Fonda, and Dennis Hopper. Issues of civil rights, the Vietnam War (and ensuing protests), political scandal, and the emerging generation gap fueled our obsession with wind-swept freedom and ingrained Easyriders with its overarching sense of rebellion.

More than a magazine, Easyriders is a lifestyle.

In celebration of our 50th anniversary, we are shifting with the times and expanding the brand to encompass exclusive, major-label product collaborations; insider events and music festivals; and a quarterly coffee table–style book — that’s four thick issues per year jam-packed with gorgeous photography and feature stories.

With a nod to our roots in independence, passion, and freedom, and with a newfound emphasis on international travel, design, and entertainment, Easyriders has flown full throttle into a new era. Join us as we embark on this next journey.

Website:  www.easyriders.com

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate“, “continue“, “estimate”, “expect”, “may”, “will”, “would”, “project“, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Posted on

Hollister Cannabis Co. To Sponsor Exclusive Adult Consumption Area in “The Den” of Dream House MJBiz Event

Hollister Cannabis Co., is pleased to announce its sponsorship of the Dream House MJBiz VIP Event in Las Vegas, Nevada. The most-anticipated after-party of the MJBiz Conference presented by Farechild will take place on December 12, 2019, in close proximity to the famous Las Vegas strip. Hollister Cannabis Co. will be showcasing Hemp and THC products while offering VIP’s an exclusive on-site adult consumption area in “The Den.” The invite-only after-party promises to transport guests to a world of eccentric opulence as they peruse the many different rooms of the “Dream House.” A grand-bar in the foyer, a king’s table adorned with delicacies in the dining-hall, unforgettable photo-ops in the library and a 1.8-acre outdoor courtyard where guests will be able to experience a once-in-a-lifetime activity that will be sure to leave them on a high. “The Den,” will offer VIP’s an opportunity to sample Hollister’s Rebel Hemp Company’s first hemp product, Rebel Tea, alongside the brand’s flagship product, a hash-infused premium pre-roll.

The CEO of Hollister, Carl Saling shared, “We are thrilled to be the main THC sponsor of the Dream House event during the largest cannabis show in the world, MJBizcon.”

About Dream House MJBiz VIP Event by Farechild

For the last three years, the founders of Farechild produced the most anticipated after-party of MJBiz with their infamous DOPE Magazine Golden Ticket Party. This year, all eyes will be on the very first Farechild produced “Dream House” event. Farechild, and its partners, will host guests in an elaborate 10,000 square foot space just a stone’s throw from the famous Las Vegas Strip.